Limited Competition: Resources and Workforce Development for the Regional Biocontainment Laboratories
Forecast
National Institutes of Health plans to offer grants to colleges and universities. It expects to make about 12 awards worth $36.0 million in total. It is a forecast: the notice is expected around July 2, 2027, with applications due around September 30, 2027.
From the official notice on Grants.gov, last changed June 24, 2026. Checked October 31, 2026.
- Award ceilingnot stated
- Award floornot stated
- Expected awards12
- Total funding$36.0 million
- Cost sharingNot required
- Funding typeCooperative Agreement
Key dates
| Forecast posted | June 24, 2026 |
|---|---|
| Expected posting | July 2, 2027 |
| Expected deadline | September 30, 2027 |
| Expected award date | August 1, 2028 |
Add the deadline to your calendar
Who can apply
This opportunity is open to colleges and universities.
- Public and State controlled institutions of higher education
- Private institutions of higher education
Eligible ApplicantsUniversity of Alabama at BirminghamTulane UniversityUniversity of TennesseeGeorge Mason UniversityDuke UniversityRutgers UniversityTufts UniversityUniversity of PittsburghUniversity of ChicagoUniversity of MissouriUniversity of LouisvilleColorado State University
Is this a realistic fit?
- No cost sharing or match is required.
What the grant funds
The National Institute of Allergy and Infectious Diseases (NIAID) seeks to advance its mission by providing critical resources, staff and facilities support for the Regional Biocontainment Laboratories (RBLs). The RBLs provide biosafety level 2 and 3 (BSL-2/3) biocontainment facilities for research on infectious diseases. They play a critical role in public health emergency response by facilitating key activities related to infectious disease outbreaks and biosafety/biosecurity concerns. Congress has denoted the RBLs a NIAID research priority. This program will provide multi-year funding for facility maintenance, operations and biocontainment-specific training for personnel to maintain a capable BSL-3 level workforce in the United States. This is a Forecast for a Limited Competition that will invite application(s) from eligible organization(s) to apply. Please see the Eligibility Section for additional information. In accordance with NIH standard peer-review processes, the application(s) will be peer-reviewed, and only meritorious application(s) will be considered for funding. Grant authorities that allow NIAID to forecast this opportunity are as follows: Sections 301 and 405 of the Public Health Service Act as amended (42 USC 241 and 284) and under Federal Regulations 42 CFR Part 52 and 2 CFR Part 200.
How to apply
- Read the full notice and attachments on Grants.gov. The notice is the official source for deadlines and requirements.
- Make sure your organization has an active SAM.gov registration and Unique Entity ID; registration can take several weeks.
- Register on Grants.gov and submit through Workspace before the deadline and time given in the notice. Our application guide walks through each step.
Questions go to NIAID RBL-NBL (Division of Microbiology and Infectious Diseases), NIAIDRBL-NBL@mail.nih.gov, Please contact via email..
Questions people ask
Who can apply for Limited Competition: Resources and Workforce Development for the Regional Biocontainment Laboratories?
National Institutes of Health accepts applications from colleges and universities. The notice adds further conditions, so read its eligibility section.
What is the deadline for Limited Competition: Resources and Workforce Development for the Regional Biocontainment Laboratories?
Expected deadline September 30, 2027. Confirm the date and time in the official notice on Grants.gov.
How much funding is available?
About $36.0 million in total across about 12 awards.
Similar open grants
- Continuation of the Collaborative Islet Transplantation Registry (U01 Clinical Trial Not allowed)
- BRAIN Initiative Cell Atlas Network (BICAN): Coordinating Unit for Biostatistics, Informatics, and Engagement (CUBIE)
- Centers without Walls for mechanisms of neurodegeneration in Alzheimer’s disease-related dementias (ADRD)
- Expanding the Therapeutic Pipeline for Treating and Preventing Alzheimer's Disease and Related Dementias: Preclinical Validation and Drug Discovery for Novel Candidate Targets (U01 Clinical Trial Not Allowed)
- Systematic Testing of Radionuclides in Preclinical Experiments (STRIPE, RP1 Clinical Trial Not Allowed)
- Exposomic Contributions to ADRD Pathology and Resilience